Valuation: Forian Inc.

Market Cap 67.79M 59.24M 54.67M 50.39M 94.98M 6.53B 97.09M 653M 257M 3.2B 255M 249M 11.01B P/E 2024
-17x
P/E 2025 -22.9x
Enterprise Value 36.25M 31.68M 29.24M 26.95M 50.79M 3.49B 51.92M 349M 137M 1.71B 136M 133M 5.89B EV / Sales 2024
1.76x
EV / Sales 2025 1.13x
Free-Float
56.56%
Yield 2024 *
-
Yield 2025 -
1 day+0.46%
3 months+0.93%
6 months+3.83%
Current year+2.36%
Current year 2.01
Extreme 2.01
2.2
1 year 1.64
Extreme 1.64
2.71
3 years 1.64
Extreme 1.64
4.15
5 years 1.64
Extreme 1.64
12.64
10 years 1.64
Extreme 1.64
45
Manager TitleAgeSince
Corporate Officer/Principal 60 15/10/2020
Chief Executive Officer 38 10/02/2023
Director of Finance/CFO 64 02/09/2021
Director TitleAgeSince
Chairman 38 15/10/2020
Date Insider Type Main position Quantity % Market Cap.
15/5/26 Issuer sale

Founder

-4,537,059 14.5828%
15/5/26 Tender

Director

-80,000 0.2571%
15/5/26 Tender

Director

-103,757 0.3335%
Change 5-day change 1-year change 3-year change Capi.($)
+0.46%-.--%+10.71%-17.49% 67.79M
-1.01%+2.77%-30.79%-6.68% 31.74B
-3.46%-5.05%-42.95%+184.23% 13.65B
-1.43%-2.55%-24.06%+67.70% 5.5B
-4.20%-6.89% - - 2.15B
-2.40%+2.11%+70.65%-32.02% 2.09B
-0.73%-5.34% - - 1.74B
-4.23%-2.47%-39.86% - 1.07B
-3.80%-5.00%+45.69%+106.33% 901M
-6.74%-2.64%-41.34%-55.97% 759M
Average -2.75%-2.41%-6.49%+35.16% 5.97B
Weighted average by Cap. -1.94%-0.40%-28.34%+48.64%

Financials

2024 2025
Net sales 20.15M 17.61M 16.25M 14.98M 28.23M 1.94B 28.86M 194M 76.4M 951M 75.69M 74.02M 3.27B 30.26M 26.44M 24.4M 22.49M 42.39M 2.91B 43.33M 292M 115M 1.43B 114M 111M 4.91B
Net income -3.77M -3.3M -3.04M -2.8M -5.28M -363M -5.4M -36.35M -14.3M -178M -14.16M -13.85M -612M -2.87M -2.51M -2.32M -2.14M -4.03M -277M -4.12M -27.7M -10.9M -136M -10.79M -10.56M -467M
Net Debt -28.35M -24.77M -22.86M -21.07M -39.72M -2.73B -40.6M -273M -107M -1.34B -106M -104M -4.6B -31.54M -27.56M -25.43M -23.44M -44.19M -3.04B -45.17M -304M -120M -1.49B -118M -116M -5.12B
Logo Forian Inc.
Forian Inc. is a healthtech company. It is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. It provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers within the healthcare and life sciences and financial services industries. It has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its solutions include CHRONOS, Chartis, real-world evidence (RWE) and Kyber Data Science. CHRONOS combines open and closed claims, electronic health records, and social determinants of health data into a single, integrated model. It also provides researchers access to healthcare payers, providers, and clinical data with non-traditional healthcare sources, such as social determinants of health (SDoH) data, to uncover novel insights.
Employees
50
  1. Stock Market
  2. Stocks
  3. FORA Stock